Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Intra-Cellular Therapies, Inc. | Financial_Report.xls |
| EX-31.1 - EX-31.1 - Intra-Cellular Therapies, Inc. | d857051dex311.htm |
| EX-31.2 - EX-31.2 - Intra-Cellular Therapies, Inc. | d857051dex312.htm |
| EX-32.1 - EX-32.1 - Intra-Cellular Therapies, Inc. | d857051dex321.htm |
| EX-10.2.2 - EX-10.2.2 - Intra-Cellular Therapies, Inc. | d857051dex1022.htm |
| 10-K - FORM 10-K - Intra-Cellular Therapies, Inc. | d857051d10k.htm |
| EX-10.11 - EX-10.11 - Intra-Cellular Therapies, Inc. | d857051dex1011.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statement (Form S-3 No. 333-198496) of Intra-Cellular Therapies, Inc., |
| (2) | Registration Statement (Form S-3 No. 333-191238) of Intra-Cellular Therapies, Inc., and |
| (3) | Registration Statement (Form S-8 No. 333-193310) pertaining to the ITI, Inc. 2003 Equity Incentive Plan, as amended, and the Intra-Cellular Therapies, Inc. 2013 Equity Incentive Plan of Intra-Cellular Therapies, Inc.; |
of our report dated March 12, 2015, with respect to the consolidated financial statements of Intra-Cellular Therapies, Inc. included in this Annual Report (Form 10-K) of Intra-Cellular Therapies, Inc. for the year ended December 31, 2014.
/s/ Ernst & Young LLP
McLean, VA
March 12, 2015